-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
4-[Bis(1,1-dimethylethyl)phosphino]-N,N-dimethylbenzenamine, also known as the compound TMP-DB, is a synthetic intermediate commonly used in the chemical industry.
This compound is used as a building block for the synthesis of a variety of chemicals and materials, including dyes, pigments, pharmaceuticals, and agrochemicals.
TMP-DB can be synthesized through a variety of routes, including synthetic and natural routes.
Synthetic routes
The synthetic routes to TMP-DB can be broadly classified into two categories: direct and indirect.
The direct route involves the reaction of dimethylphosphinoacetaldehyde with N-dimethylaminobenzene in the presence of a catalyst, such as tetrakis(dimethylaminomethyl)phenolphosphonium chloride.
This reaction leads to the formation of 4-[bis(1,1-dimethylethyl)phosphino]-N,N-dimethylbenzenamine.
The indirect route involves the synthesis of TMP-DB through the intermediate compound N,N-dimethyl-2-chloro-4-nitrophenamine.
This compound can be synthesized by the reaction of N-dimethylaminobenzene with chloroacetamide in the presence of a catalyst, such as sodium hydroxide.
The N,N-dimethyl-2-chloro-4-nitrophenamine can then be reduced to TMP-DB using a reducing agent, such as lithium aluminum hydride.
Indirect route
The indirect route is more commonly used in the industry, as it allows for the synthesis of TMP-DB in larger quantities and with higher purity.
This route has several advantages over the direct route, including higher yield, better control over the reaction conditions, and reduced cost.
The indirect route involves several steps, including the synthesis of N,N-dimethyl-2-chloro-4-nitrophenamine, its reduction to N-(2,6-dimethylphenyl)-N-(1,3-dimethyl-2-oxobutyl)-hydrazinecarbothioamide, and the reduction of this hydrazone to TMP-DB.
The synthesis of N,N-dimethyl-2-chloro-4-nitrophenamine begins with the reaction of N-dimethylaminobenzene with chloroacetamide in the presence of sodium hydroxide.
This reaction leads to the formation of N,N-dimethyl-2-chloro-4-nitrophenamine, which can then be purified and used in the subsequent steps of the process.
The next step involves the reduction of N,N-dimethyl-2-chloro-4-nitrophenamine to N-(2,6-dimethylphenyl)-N-(1,3-dimethyl-2-oxobutyl)-hydrazinecarbothioamide using a reducing agent, such as lithium aluminum hydride.
The final step involves the reduction of N-(2,6-dimethylphenyl)-N-(1,3-dimethyl-2-oxobutyl)-hydrazinecarbothioamide to TMP-DB using a reducing agent, such as tris(hydroxymethyl)nitromethane or lithium hydroxide.
Applications
TMP-DB is a versatile synthetic intermediate that is used in the production of various chemicals and materials.
It is commonly used as a building block for the synthesis of pharmaceuticals, agrochemicals, and pigments.
In the pharmaceutical industry, TMP-DB is used in the synthesis of anti